Search

everythinglearnresearchcommunity

for

Search:↓

Hair loss, known as Androgenetic Alopecia, is often caused by hormones and can be diagnosed using noninvasive techniques. Treatments include topical minoxidil and oral finasteride, with new treatments being explored. There may also be a link between this type of hair loss and heart disease risk.

Hydrogel composites have great potential in regenerative medicine, tissue engineering, and drug delivery.

A new method using a microfluidic device can prepare hair follicle germs efficiently for potential use in hair loss treatments.

Scientists created a gel with nanoparticles to deliver medicine to hair follicles effectively.

Particle properties affect drug retention and release in minoxidil foams, with lipid nanoparticles having higher loading capacity.

Insulin resistance contributes to hormone imbalances in many women with polycystic ovary syndrome.

Prostaglandin E2 affects human platelet activity in complex ways that could lead to personalized heart disease treatments.

Estrogens are key for bone growth spurts in both boys and girls and affect growth into adulthood.

Finasteride reduces testosterone conversion, progesterone lessens this, and levamisole enhances finasteride's effect.

Stress and hormones like progesterone can affect absence seizures, but their effects change with different life stages.

Finasteride reduces alcohol withdrawal severity and anxiety in mice, but may increase withdrawal severity in some cases.

Sex hormones affect reproduction, sexual development, and oral health, and it's important for dental practitioners to understand their effects and interactions.

Oestrogens are key for bone growth during puberty in both boys and girls.

Smart biomaterials that guide tissue repair are key for future medical treatments.

HFMs can help study hair growth and test potential hair growth drugs.

Dutasteride makes alcohol less sedating and may lead to less drinking in men.

Finasteride reduces alcohol withdrawal effects, especially in female mice.

Finasteride use may lead to less alcohol consumption in men with lasting sexual side effects.

R-spondins and their receptors help increase bone growth and may be used to treat bone loss diseases.

Using polyethylenimine-DNA to deliver the hTERT gene can stimulate hair growth and may be useful in treating hair loss, but there could be potential cancer risks.

Centella asiatica extract may help promote hair growth.

AGA is a common hair loss affecting both genders, treated with various therapies to promote regrowth and slow thinning.

The enzyme steroid sulfatase is linked to breast cancer and other conditions, and inhibitors are being developed for treatment.

Teriflunomide helps reduce multiple sclerosis symptoms and is safe for most patients.

Wnt1/βcatenin signaling is crucial for heart repair after injury.

Periodontal ligament stem cells show promise for regrowing tissues but require more research for safe, effective use.

GABRA2 gene variations impact alcohol response, and hair loss medication finasteride reduces some effects.

Inflammation may be linked to hair loss, and targeting specific enzymes could help treat it.

Asia has made significant progress in tissue engineering and regenerative medicine, but wider clinical use requires more development.

The Wnt/β-catenin pathway is important for tissue development and has potential in regenerative medicine, but requires more research for therapeutic use.